CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Grant or award 10% owner acquired 2,101,496 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 140,000 shares (grant or award)
- 4 Open-market buy President, CEO & Chairman bought 1,567,515 shares at $1.70 ($2,664,776)
- 4 Open-market buy See Remarks bought 147,058 shares at $1.70 ($249,999)
- 4 Open-market buy President, CEO & Chairman bought 100,000 shares at $0.28 ($28,330)
- 4 Insider Changes in Ownership
- 4 Open-market buy 10% owner bought 418,410 shares at $0.72 ($301,255)
- 4 Open-market buy President, CEO & Chairman bought 20,000 shares at an average $10.55 ($210,900)
- 4 Insider Changes in Ownership
- 4 Grant or award 10% owner acquired 52,419 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Open-market buy See Remarks bought 1,197,604 shares at $0.84 ($999,999)
- 4 Open-market buy Director bought 11,976 shares at $0.84 ($10,000)
- 4 Open-market buy President, CEO & Chairman bought 2,395,209 shares at $0.84 ($2,000,000)
- 4 Open-market buy Director bought 11,976 shares at $0.84 ($10,000)
- 4 Open-market buy Director bought 299,401 shares at $0.84 ($250,000)
- 4 Open-market buy Chief Financial Officer bought 35,928 shares at $0.84 ($30,000)
- 4 Grant or award 10% owner acquired 2,807,008 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Grant or award President, CEO & Chairman acquired 1,223,558 shares (grant or award)
Page 4 of 15 · 289 filings